ClinicalTrials.govpublic full text
Effect of Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease
type 2 diabetes mellitus with complication
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 136266
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.